Clinical trials: Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Depression, Excessive Daytime Sleepiness
Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder
This concurrent, two-part study will: I) Using overnight sleep recordings, evaluate the short- and long-term sleep-promoting effects of the antidepressant mirtazapine (Remeron) in patients who have been prescribed this medication…
- Trial name
- NCT00385437
- Testing
- Driving Simulator Testing, Mirtazapine Treatment
- Where
- Canada
- Volunteers
- 16 people
- Sponsor
- University Health Network, Toronto
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal trial in patients with major…
- Trial name
- CLARITY (NCT07484217)
- Testing
- Solriamfetol 150 MG
- Where
- 40 sites in United States
- Volunteers
- 508 people
- Sponsor
- Axsome Therapeutics, Inc.